Department of Translational Medicine, University of Ferrara, via Luigi Borsari 46, 44121 Ferrara, Italy.
Cell Rep Med. 2023 Sep 19;4(9):101163. doi: 10.1016/j.xcrm.2023.101163.
Metabolic reprogramming of CD4 T cells has become an opportunity for adjunctive therapies. Here, Han et al. show that boosting NAD blunts systemic Th17 responses and increases antioxidant pathways through arginine and fumarate-mediated activation of NRF2 transcription factor.
CD4 T 细胞的代谢重编程已成为辅助治疗的机会。在这里,Han 等人表明,提高 NAD 水平可通过精氨酸和富马酸介导的 NRF2 转录因子激活来减轻全身性 Th17 反应并增加抗氧化途径。